AI Tool Supports Noninvasive Continuous Dyspnea Monitoring in Ventilated Patients

Shortness of breath, or dyspnea, is a common yet difficult-to-detect symptom in acute and critical care. Clinicians often rely on oxygen saturation to gauge respiratory status, but normal readings can mask severe distress. Missed recognition can worsen the experience of patients on mechanical ventilation and may contribute to longer-term morbidity. Researchers have now identified carbon dioxide as the dominant driver of breathlessness and outlined a noninvasive, machine-learning approach to continuously monitor dyspnea.

Researchers at the University of California, Riverside conducted controlled laboratory experiments with nearly 70 healthy participants, inducing dyspnea by adjusting oxygen and carbon dioxide levels. The work showed that carbon dioxide is the principal stimulus for the sensation of breathlessness, while oxygen levels correlate poorly with perceived respiratory discomfort. The study underscores that outward appearance can be misleading, as individuals who look calm may still report intense distress.

The findings challenge routine dependence on oxygen saturation (SpO2) alone to detect respiratory discomfort. They reinforce evidence around “silent hypoxemia,” in which patients have dangerously low oxygen levels without dyspnea, or feel severe breathlessness despite normal readings. For mechanically ventilated patients, low tidal volumes used to prevent lung injury can intensify the sensation of suffocation, particularly when patients are sedated or unable to communicate.

The research team is developing a predictive tool that uses a machine-learning algorithm to detect dyspnea from noninvasive biomarkers. The goal is continuous monitoring that complements existing measures and supports timely, patient-centered interventions. The study appears in Respiratory Physiology & Neurobiology and highlights the need for better education on dyspnea, which remains underrecognized compared to pain, as well as its clinical relevance in chronic conditions such as chronic obstructive pulmonary disease.

“This challenges a common clinical practice. Clinicians often rely on oxygen saturation in the blood (SpO2) to assess patients. But oxygen levels are often a poor predictor of how breathless someone feels. Carbon dioxide is a much more important driver of this sensation,” said Erica Heinrich, an assistant professor of biomedical sciences in the UCR School of Medicine.

“We need to take dyspnea as seriously as pain. That means better training, better monitoring, and rethinking how we balance lung protection with patient comfort. At its core, the message is simple but urgent: Dyspnea matters,” said Heinrich.

Related Links
UCR School of Medicine